OpenAI Escapes Microsoft's Grasp: New Possibilities
In this episode, we analyze how OpenAI has escaped Microsoft's grasp, leading to new possibilities. Additionally, we spotlight the $1.1 billion funding raised by AlphaGo's architect. See Privacy Poli...
27 Apr 16min
ChatGPT 5.5: A Closer Look
In this episode, we take a closer look at the ChatGPT 5.5 launch. We will also touch upon SpaceX's advancements in GPU production. See Privacy Policy at https://art19.com/privacy and California Priva...
24 Apr 16min
Focusing on Google’s AI Strategy Updates
In this episode, we focus on the latest updates surrounding Google’s multi-layer AI strategy shared at Cloud Next. Gain a comprehensive understanding of its implications. See Privacy Policy at https:...
22 Apr 16min
New Apple CEO, OpenAI's New Image Model, Vercel AI Hack
In this episode, we explore the significant leadership change at Apple as Tim Cook steps down and John Tarnas takes the helm, amid ongoing challenges in the AI sector. We also discuss major developmen...
21 Apr 16min
Anthropic's Financial Success Compared to OpenAI
In this episode, we discuss Anthropic's financial success in comparison to OpenAI. Explore the impact of this change on the AI field. See Privacy Policy at https://art19.com/privacy and California Pr...
20 Apr 14min
OpenAI's Codex and Claude: A Comprehensive Overview
In this episode, we present a comprehensive overview of both OpenAI's Codex and Anthropic's Claude. Dive into their features, implications, and future potential. See Privacy Policy at https://art19.c...
17 Apr 14min
Anthropic's Launch: $2 Billion Opus 4.7 Insights
In this episode, we shed light on Anthropic's launch of Opus 4.7 and the implications of its $2 billion funding. We also discuss relevant partnerships with Google AI. See Privacy Policy at https://ar...
16 Apr 14min
Why Anthropic's IPO Deserves Attention
In this episode, we discuss why Anthropic's IPO should capture our attention in the AI landscape. We also highlight the implications of the new brain sensor technology from Novo Nordisk and OpenAI. S...
15 Apr 15min
